Updates are available Correction dated 2026-03-28

Article History

Received: 3 November 2025

Revised: 15 December 2025

Accepted: 17 December 2025

First Online: 3 January 2026

Change Date: 12 February 2026

Change Type: Update

Change Details: The original online version of this article was revised: due to the author names were swapped incorrectly in the article.

Change Date: 28 March 2026

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s00415-026-13669-5

Declarations

:

: L.-I.S., M.L., J.L., M.S., C.D. and M.F. declare that they have no financial interests. Author S.N. has received speaker honoraria from Roche and Biogen. B.S. has received speaker honoraria and travel reimbursement from Biogen. R.P. received speaker honoraria from Alexion, Amgen/Horizon, Bayer Healthcare, Biogen, Bristol-Mayers Squibb/Celgene, Merck, Mylan, Novartis, Roche, and Sanofi as well as research support from Bristol-Mayers Squibb, Merck, Neuraxpharm, and Novartis. J.S. received speaker honoraria from Alexion, Merck, Roche, and Sanofi, and travel support from Sanofi. C.K. received lecture and consultancy fees from Biogen, Roche, and Novartis. T.H. received lecture and consultancy fees from Biogen, Roche and Novartis, as well as research support from Biogen, Roche, and Novartis Gene Therapies.

: Participants provided written informed consent prior to their inclusion in the study. The study was approved by the local ethics committee of the University of Duisburg-Essen, Germany (approval number 18-8071-BO).